Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

A phase 2, open-label study of the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of DISC-3405 in participants with polycythemia vera (PV)

Blood (2025) 146 (Supplement 1): 2053.

https://doi.org/10.1182/blood-2025-2053

Published: 2025

Journal Articles

Redefining hematology referral thresholds for eosinophilia: A 10-year experience at an academic medical center

Payal Patel, Corinne Lavasseur, Joseph Shatzel, Thomas Deloughery

Blood (2025) 146 (Supplement 1): 2985.

https://doi.org/10.1182/blood-2025-2985

Published: 2025

Journal Articles

Efficacy and safety of the LSD1 inhibitor bomedemstat in participants with polycythemia vera (PV) resistant or intolerant to cytoreductive therapy: The Phase 2 shorespan-004 study

Lindsay Rein, Alice Livings, Rebecca Frewin, Andrew Innes, Ali Mahdi, Ciro Rinaldi, Natalia Curto-Garcia, Jennifer Vaughn, Joseph Shatzel, Paul Yeh, Jessica Flynn, Jonas Jutzi, Patricia Marinello, Michael Leahy

Blood (2025) 146 (Supplement 1): 83.

https://doi.org/10.1182/blood-2025-83

Published: 2025

Journal Articles

Rusfertide or placebo plus current standard-of-care therapy for polycythemia vera: Durability of response and safety results through week 52 from the randomized controlled phase 3 VERIFY study

Blood (2025) 146 (Supplement 1): 81.

https://doi.org/10.1182/blood-2025-81

Published: 2025

Journal Articles

Single-dose IV ferric derisomaltose improves hematologic and patient-reported outcomes in pregnant individuals with iron deficiency anemia

Thalia Padilla Kelley, Kylee Martens, Monica Rincon, Lucy Ward, Adam Lewkowitz, Methodius Tuuli, Joseph Shatzel, Jamie Lo, Ashley Benson

Blood (2025) 146 (Supplement 1): 4682.

https://doi.org/10.1182/blood-2025-4682

Published: 2025

Journal Articles

Developing expert consensus for specialist e-consult response: A delphi study to inform graduate medical education

Kylee Martens, Daren Anderson, Thomas Deloughery, David Garcia, Andrew Hale, Erin Keely, Clare Liddy, Christian Mayorga, Elizabeth Miller, Sven Olson, Varsha Vimalananda, Jason Wasfy, Jason Freed, Joseph Shatzel

Blood (2025) 146 (Supplement 1): 4382.

https://doi.org/10.1182/blood-2025-4382

Published: 2025

Journal Articles

Association of delayed platelet recovery and lower nadir counts with adverse outcomes in heparin-induced thrombocytopenia

Aamna Khan, Hannah Mahjoub, Howard Chang, Aditya Malhotra, Emma Deloughery, Joseph Shatzel

Blood (2025) 146 (Supplement 1): 3115.

https://doi.org/10.1182/blood-2025-3115

Published: 2025

Journal Articles

Comprehensive analyses of patient-reported outcomes from the phase 3 VERIFY study of rusfertide or placebo plus current standard of care for polycythemia vera

Aniket Bankar, Andrew Kuykendall, Naveen Pemmaraju, Kristen Pettit, Joseph Shatzel, Alessandro Lucchesi, Valentín García Gutiérrez, Harinder Gill, Joseph Scandura, Francesca Palandri, Matthew Reaney, Cristina Ivanescu, Christina Daskalopoulou, Phil Dinh, Sarita Khanna, Suneel Gupta, Arturo Molina, David Cella

Blood (2025) 146 (Supplement 1): 5588.

https://doi.org/10.1182/blood-2025-5588

Published: 2025

Journal Articles

Should dermatologic examinations become routine standard of care in patients with polycythemia vera? Observations from the phase 3 VERIFY study prior to rusfertide exposure

Joseph Shatzel, Andrew Kuykendall, Aniket Bankar, Naveen Pemmaraju, Kristen Pettit, Alessandro Lucchesi, Valentín García Gutiérrez, Antonieta Sosa, A. Peter Morello, Pedro Oyuela, Phil Dinh, Arturo Molina

Blood (2025) 146 (Supplement 1): 5587.

https://doi.org/10.1182/blood-2025-5587

Published: 2025

Journal Articles

A Systematic Review and Meta-Analysis of Randomized Trials Examining Extended Thromboprophylaxis with Direct Oral Anticoagulants in Hospitalized Medical Patients

Derrick Tao, Jeffery Bien, MD, Joseph Shatzel, MD

Blood (2016) 128 (22): 1436.

https://doi.org/10.1182/blood.V128.22.1436.1436

Published: 2016

Journal Articles

Evaluating the Effects of an Evidence-Based Hemostasis and Thrombosis Treatment Algorithm Tool on Medical Practitioner and Trainee Clinical Decision Making

Joseph Shatzel, MD, Derrick Tao, Sven R Olson, MD, Edward Kim, Molly Daughety, MD, Thomas G. Deloughery, MD, Merav Sendowski, MD

Blood (2016) 128 (22): 4736.

https://doi.org/10.1182/blood.V128.22.4736.4736

Published: 2016

Journal Articles

Adherence Rates Between Once and Twice Daily Direct Oral Anticoagulants - Results of a Single University Pharmacy Cohort Study

Joseph Shatzel, MD, Molly Daughety, MD, Derrick Tao, Edward Kim, Sven Olson, MD, Ali Olyaei, Pharm.D, Thomas G. Deloughery, MD

Blood (2016) 128 (22): 5024.

https://doi.org/10.1182/blood.V128.22.5024.5024

Published: 2016

Journal Articles

The Effectiveness and Safety of Direct Oral Anticoagulants (DOACs) Vs. Traditional Anticoagulants in Patients with Cirrhosis

Justin Hum, MD, Janice Jou, Thomas G. Deloughery, MD, Joseph Shatzel, MD

Blood (2016) 128 (22): 5015.

https://doi.org/10.1182/blood.V128.22.5015.5015

Published: 2016

Journal Articles

The Clinical Associations and Outcomes of Patients Admitted with Acquired Hemophilia; A Review of the 2012 National Inpatient Sample

Joseph Shatzel, MD, Sharl Azar, MD, Nathanael David Gay, MD, Jai Luo, MD, Thomas G. Deloughery, MD, Michael Recht, MD PhD, Jason A. Taylor, MD PhD

Blood (2015) 126 (23): 1091.

https://doi.org/10.1182/blood.V126.23.1091.1091

Published: 2015

Journal Articles

The Epidemiology and Clinical Associations of Stroke in Patients with Acute Myeloid Leukemia: A Review of 10,972 Admissions from the 2012 National Inpatient Sample

Taeha Kim, MD, Joseph Shatzel, MD, Harley Friedman, MD, Frederick Lansigan, MD

Blood (2015) 126 (23): 1314.

https://doi.org/10.1182/blood.V126.23.1314.1314

Published: 2015

Journal Articles

Characteristics of Upper Extremity Deep Vein Thrombosis in Hospitalized Patients. a Review of 8350 Admissions from the 2012 National Inpatient Sample

Taeha Kim, MD, Joseph Shatzel, MD, Deborah L Ornstein, MD

Blood (2015) 126 (23): 2314.

https://doi.org/10.1182/blood.V126.23.2314.2314

Published: 2015

Journal Articles

Decitabine Is More Cost Effective Than Standard Conventional Induction Therapy In Elderly Acute Myeloid Leukemia Patients

Nicolas Batty, MD, Samuel Wiles, Mathew Kabalan, Rohit Sharma, MD, Joseph Shatzel, MD, Jonathan Pang, David Yi, Iris Alatovic, Sana Saif, MD, Deepika Narasimha, Joseph LaPenna, Anthony Troitino, MD, Kristopher Attwood, MS, Yong Yin, PhD, Meir Wetzler, MD

Blood (2013) 122 (21): 2699.

https://doi.org/10.1182/blood.V122.21.2699.2699

Published: 2013

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

A phase 2, open-label study of the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of DISC-3405 in participants with polycythemia vera (PV)

Redefining hematology referral thresholds for eosinophilia: A 10-year experience at an academic medical center

Efficacy and safety of the LSD1 inhibitor bomedemstat in participants with polycythemia vera (PV) resistant or intolerant to cytoreductive therapy: The Phase 2 shorespan-004 study

Rusfertide or placebo plus current standard-of-care therapy for polycythemia vera: Durability of response and safety results through week 52 from the randomized controlled phase 3 VERIFY study

Single-dose IV ferric derisomaltose improves hematologic and patient-reported outcomes in pregnant individuals with iron deficiency anemia

Developing expert consensus for specialist e-consult response: A delphi study to inform graduate medical education

Association of delayed platelet recovery and lower nadir counts with adverse outcomes in heparin-induced thrombocytopenia

Comprehensive analyses of patient-reported outcomes from the phase 3 VERIFY study of rusfertide or placebo plus current standard of care for polycythemia vera

Should dermatologic examinations become routine standard of care in patients with polycythemia vera? Observations from the phase 3 VERIFY study prior to rusfertide exposure

A Systematic Review and Meta-Analysis of Randomized Trials Examining Extended Thromboprophylaxis with Direct Oral Anticoagulants in Hospitalized Medical Patients

Evaluating the Effects of an Evidence-Based Hemostasis and Thrombosis Treatment Algorithm Tool on Medical Practitioner and Trainee Clinical Decision Making

Adherence Rates Between Once and Twice Daily Direct Oral Anticoagulants - Results of a Single University Pharmacy Cohort Study

The Effectiveness and Safety of Direct Oral Anticoagulants (DOACs) Vs. Traditional Anticoagulants in Patients with Cirrhosis

The Clinical Associations and Outcomes of Patients Admitted with Acquired Hemophilia; A Review of the 2012 National Inpatient Sample

The Epidemiology and Clinical Associations of Stroke in Patients with Acute Myeloid Leukemia: A Review of 10,972 Admissions from the 2012 National Inpatient Sample

Characteristics of Upper Extremity Deep Vein Thrombosis in Hospitalized Patients. a Review of 8350 Admissions from the 2012 National Inpatient Sample

Decitabine Is More Cost Effective Than Standard Conventional Induction Therapy In Elderly Acute Myeloid Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only